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Background: Electrochemotherapy is a local treatment that utilizes electric pulses in order to achieve local increase
in cytotoxicity of some anticancer drugs. The success of this treatment is highly dependent on parameters such as
tissue electrical properties, applied voltages and spatial relations in placement of electrodes that are used to
establish a cell-permeabilizing electric field in target tissue. Non-thermal irreversible electroporation techniques for
ablation of tissue depend similarly on these parameters. In the treatment planning stage, if oversimplified
approximations for evaluation of electric field are used, such as U/d (voltage-to-distance ratio), sufficient field
strength may not be reached within the entire target (tumor) area, potentially resulting in treatment failure.
Results: In order to provide an aid in education of medical personnel performing electrochemotherapy and
non-thermal irreversible electroporation for tissue ablation, assist in visualizing the electric field in needle electrode
electroporation and the effects of changes in electrode placement, an application has been developed both as a
desktop- and a web-based solution. It enables users to position up to twelve electrodes in a plane of adjustable
dimensions representing a two-dimensional slice of tissue. By means of manipulation of electrode placement, i.e.
repositioning, and the changes in electrical parameters, the users interact with the system and observe the
resulting electrical field strength established by the inserted electrodes in real time. The field strength is calculated
and visualized online and instantaneously reflects the desired changes, dramatically improving the user friendliness
and educational value, especially compared to approaches utilizing general-purpose numerical modeling software,
such as finite element modeling packages.
Conclusion: In this paper we outline the need and offer a solution in medical education in the field of
electroporation-based treatments, e.g. primarily electrochemotherapy and non-thermal irreversible tissue ablation.
We present the background, the means of implementation and the fully functional application, which is the first of
its kind. While the initial feedback from students that have evaluated this application as part of an e-learning course
is positive, a formal study is planned to thoroughly evaluate the current version and identify possible future
improvements and modifications.
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Electroporation
Electroporation is a term coined in the early 1980's
[1] for phenomena already described more than a dec-
ade earlier [2], when an interesting property of bio-
logical membranes has been observed. Electroporation
mainly results in transient increase in membrane per-
meability when these membranes – which are mainly
composed of lipid bilayers – are exposed to very short
and intense electric fields. The physical mechanism
responsible for increased permeability is thought to be
the formation of nano-scale defects termed pores (thus
electroporation) in the lipid structure [3,4]. This
allows molecules that usually do not cross the mem-
brane to cross it with relative ease, though the exact
mechanism of this transport remains a subject of sci-
entific debate [5]. In case the electric field strength is
too high, changes to membrane structures and conse-
quently to the cell are not temporary, but instead
result in cell death, a phenomenon known as irrevers-
ible electroporation. On the other hand, if the cells
survive, increased permeability of membrane is only
temporary and the phenomenon is termed reversible
electroporation. This observed transient increase in
permeability of electroporated membranes of bio-
logical cells has offered opportunities for extensive re-
search and development resulting in a number of
applications of electroporation, such as gene (DNA)
delivery, introduction of drugs into cells, fusion of
cells, electrochemotherapy for treatment of cancer,
gene delivery in tissue and transdermal delivery of
drugs and genes as well as a number of other applica-
tions, see for instance [6,7] for an overview. In these
applications viability of the porated cells is important
and thus irreversible electroporation is consciously
avoided and generally considered to be an undesired
side effect. However, there are also interesting medical
applications of irreversible electroporation [8], such as
non-thermal irreversible electroporation for tissue abla-
tion. Irreversible electroporation is also rapidly entering
the domains of industrial [9,10] and environmental [11]
applications.
Electrochemotherapy
Electrochemotherapy (ECT) is a local treatment that
successfully combines application of cell-membrane-per-
meabilizing electric pulses and chemotherapeutic drugs.
For successful ECT, the pulses must be of adequate
amplitude, duration, number, repetition frequency and
shape [12], in order to achieve local increase in uptake
and hence cytotoxicity of otherwise non-permeant or
poorly permeant anticancer drugs. Two drugs have been
identified as candidates for ECT: bleomycin and cis-
platin [13,14]. The transport of bleomycin across thenonpermeabilized plasma membrane is highly limited
[15]. Using electroporation to increase membrane per-
meability provides bleomycin with access to cytosol and
DNA, where it causes DNA breakdown. The cytotoxicity
of bleomycin is thereby increased by a factor of several
thousand [16]. In short, the main mechanism of ECT is
the electroporation of cells in tumors and consequent
increase in drug effectiveness by enabling the drug to
reach intracellular targets. For other supporting mecha-
nisms, see [17,18].
Since all clonogenic cells in the tumor need to be
eradicated for effective treatment, all cells have to be
permeabilized, i.e. all cells in the tumor have to be
exposed to appropriate electric pulses. This means
that the effectiveness of electrochemotherapy depends
on both the drug availability in the tumor and cover-
age of the whole target area by a sufficiently high
electric field [19].
There are several factors in ECT of tumors that we
must consider before we can confidently assume we
have successfully electroporated the entire tumor area.
First, there is the issue of tumor and surrounding tissue
electrical properties that may exhibit considerable in-
homogeneity. Conductivity is of particularly high im-
portance for example, since higher tumor conductivity
compared to surrounding tissue results in lower electric
field strength in the tumor and undesirably high fields
in the surrounding healthy area that may cause irre-
versible electroporation [20]. Second, there is the issue
of electrodes used to apply the pulses, mainly of their
shape, size and position. In general, there are two types
of electrodes – plate and needle electrodes. Plate
electrodes are non-invasive, usually parallel and with
either a fixed or adjustable distance in between the two
plates, whereas needle electrodes are used invasively,
which ensures good electrical contact, but has other
drawbacks. In using plate electrodes, we must ensure
good electrical contact and optimal distance between
electrodes to fit the tumor [21,22] and with needle elec-
trodes – since electric field distribution is more in-
homogeneous and dependent on their diameter,
distance between them and depth of insertion [23] –
the task of ensuring entire tumor area coverage is even
more arduous [19].
Several papers have been published based on nume-
rical modeling, e.g. [19,24] and in vivo studies [25] on
importance of tumor coverage by sufficiently high elec-
tric fields for successful ECT, demonstrating the need
for careful consideration and control of variables. Effect-
iveness of ECT has been confirmed in a study conducted
by a consortium of four medical institutions gathered in
the ESOPE (European Standard Operating Procedures of
Electrochemotherapy) project, in the scope of which
standard operating procedures for ECT were published
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[27] or liver metastasis tumor treatment [28], the need
for patient-specific treatment planning has been high-
lighted and is being developed [29,30].
Non-thermal irreversible electroporation for tissue
ablation and other techniques
Irreversible electroporation has been studied exten-
sively in recent years as a method of tissue ablation.
While the high number of applied pulses used to
achieve classical irreversible electroporation may also
cause thermal damages due to Joule heating of the
current-conducting tissue, non-thermal irreversible
electroporation (NTIRE) is of particular interest since
it results in well-defined areas of tissue ablation and
no protein coagulation [31]. The potential clinical
applications of NTIRE are therefore numerous. It is
technically a simple procedure, requiring only the in-
sertion of electrode needles without any addition of
chemotherapeutic as with ECT; it is fast in comparison
to other ablation methods such as RF ablation or
cryoablation; can be monitored with ultrasound; pro-
duces a sharp delineation between treated and un-
treated regions; and affects only cells while sparing the
connective structure [8,32]. Since it has been observed
that NTIRE spares the vascular structure and nerves,
there is hope of using this technique in treatment of
tumors abutting large blood vessels [33]. Promising as
this treatment is, we are faced with similar considera-
tions as with reversible electroporation in the case of
ECT or its many other applications, namely to ensure
adequate local electric field strength, sufficient for irre-
versible, yet non-thermal electroporation.
In addition to NTIRE and ECT, a number of other
minimally invasive therapies for treatment of deep-
seated tumors (particularly those of the liver) exist, e.g.
high intensity focused ultrasound, microwave ablation
and radiofrequency ablation. The latter is a minimally
invasive procedure where a needle electrode is inserted
percutaneously into a tumor, much as in ECT or NTIRE.
The electrode acts as an antenna for electromagnetic
waves emitted by a generator; the tumor is heated up
and thereby destroyed [34]. As with NTIRE or ECT, the
need for accurate needle placement exists and its im-
portance has been evaluated. Success, i.e. improved
treatment, has been proven to be correlated to the ex-
perience of the operator [34].
The need for education on electroporation
As outlined in the paragraphs above, both reversible and
irreversible electroporation are promising approaches in
treating solid tumors, however their success is highly
dependent on local field strength. Poorly defined or un-
known properties such as tissue conductivities andinhomogeneities in addition to our choice of electrode
type, positions and pulse amplitudes, affect the electric
field distribution. With many factors to take into consi-
deration, we may dismiss important uncontrolled va-
riables or use a well-studied but irrelevant model that
cannot be applied to a specific situation. An example of
this is the persistent use of a very simple approximation
for electric field strength that holds only under very par-
ticular conditions. This frequently used approximation
equates the electric field strength E to the voltage U ap-
plied on the electrodes divided by the distance d bet-
ween the electrodes, i.e. E ≈ U/d. Since the local electric
field strength has been identified as the key factor in
achieving both reversible and irreversible electroporation
(see [19] for details), i.e. local E has to reach a certain
threshold value Erev or Eirrev, it is the parameter we most
often optimize our electrode configuration for. There is
a problem, however, since this simple relation is strictly
valid only in an isotropic homogeneous medium bet-
ween two infinitely large parallel plate electrodes. When
using parallel plate electrodes in ECT or NTIRE, this
simple model best approximates the actual field strength
far from the electrode edges, provided the electrode
width is sufficiently large compared to the electrode dis-
tance. In any case, the approximate model fails com-
pletely as we approach the edges (see Figure 1a). Results
are even worse in the case of needle electrodes, where of
course there are no parallel plates to speak of (see
Figure 1b and [35] for further elucidation). Therefore,
using the simple parallel plate approximation for E in in-
dividual cases of tumor treatment could possibly result
in significant reduction of response in treatment for
which the complete response rate has been shown to be
as high as 74% [17].
As ECT and NTIRE are steadily finding their way
into more and more clinics worldwide [36-39] and
establishing themselves as safe and effective treatments
of cancer, it is becoming more and more important
that medical personnel performing and planning ECT
(or NTIRE) is aware of their mechanisms of action,
the underlying physics and possible pitfalls. This
paper presents an application for visualization and
analysis of the electric field strength in multiple-
needle-electrode electroporation aimed at users with
basic knowledge of the principles of electroporation,
but lack of education in physics and engineering who
may therefore need visual, interactive and didactic
instruments to gain a deeper understanding of the
principles necessary for effective use of these promis-
ing treatments. Since educational applications of the
sort are scarce and research is focused primarily on
advancing the field rather than educating, the need
to explore options and applications in this area of en-
gineering education seems pressing and applicative
Figure 1 Electric field distribution for plate electrodes in a cutaneous tumor electroporation (a) and parallel needle electrodes in
cutaneous tumor electroporation (b). Geometry is shown on the left hand side and resulting field strength on the right. Tumor diameter in
both instances is 2 cm, electrode thickness 0.2 cm and electrode distance 1.6 cm. The applied voltage was 1300 V. Resulting field strength on the
color scale is in volts per meter.
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of a now firmly established annual course Electropor-
ation Based Technologies and Treatments, EBTT
(http://www.ebtt.org). The e-learning laboratory exer-
cise into which the presented application has been




The theoretical background for the mathematical en-
gine that is at the heart of our application has been
derived from the electrostatic field theory, more spe-
cifically, extended from a solution for electrostatic po-
tential generated by two long parallel charged
conductors given in [41]. We have omitted the detailed
mathematical derivations here as they are outside the
scope of this paper; however, we have included a deriv-
ation of the equations below in the Appendix for those
readers that may be interested in further development
or modifications to our model. Below, we specify only
the final formulation of the mathematical model and
the method of application of this analytical solution
into the field-calculating engine that represents the
core of Application for Visualization of Target Tissuein Electroporation (ApiVizTEP), since this is the only
essential part of the application around which the user
interface is built. Similarly to the approach that we
present in this paper, other analytical models have
been developed previously using complex analysis. For
a six-needle array, one may find a first-order analytical
approximation for the electric field strength in [42].
Other authors have expanded on this approach further,
see e.g. [43] and [44]; however, these solutions do not
give an accurate analytical expression for the electric
field strength since quite possibly such a solution can-
not be obtained for three or more electrodes active
concurrently at a given time. Since currently electro-
poration devices mostly power only one pair of elec-
trodes at a time [45], we have not pursued a solution
with more than two concurrently active electrodes, thus
avoiding the derivation of an approximate solution. In-
stead, we give an accurate solution for a two needle elec-
trode system that is not based (mathematically) on
previously published work.
The accurate analytical solution for electric field
strength of two long parallel cylindrical conductors (nee-
dle electrodes) on a plane perpendicular to the con-
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q
VAB is the voltage on an electrode pair (anode–
cathode), dAB is the distance between the electrodes, ρ0
is the electrode diameter, while x’A, y’A and x’B, y’B are
coordinates of the center of the electrode mathematical
equivalents (the electrical center x’A, y’A and x’B, y’B of
the electrodes is eccentric to the actual geometrical
center xA, yA and xB, yB due to finite i.e. non-zero elec-
trode diameter).
Our application employs a mesh of 400 × 400 points and
the electric field strength E is calculated for each of the
160.000 points using the expression above. The time
needed to perform the necessary calculations and display
the results is practically negligible, ranging from a few hun-
dred milliseconds for two active electrodes up to one and a
half seconds for twelve active electrodes using an average
modern personal computer, i.e. at least a dual core 2 GHz
processor equipped with 2 GB of memory or more. It
needs to be emphasized that while the application allows
for inclusion of up to twelve electrodes distributed into
one to six groups with variable voltages, the application
fundamentally breaks down these groups into anode–cath-
ode pairs and calculates the electric field strength by means
of the equations above for every pair. It then searches this
set of results to obtain the maximum value of the electric
field in each of the 160.000 points. This value represents
the final solution in that point, since what we are interested
in is determining the maximum value for the local field
strength. In this way we have eliminated the need for a so-
lution for the electric field of more than two concurrently
active electrodes. Such an approach is justified by the fact
that we have already mentioned – i.e. currently electropor-
ation devices only power two electrodes at the same time.
Tools and platforms
The application has been written in C# programming
language in the MicrosoftW Visual Studio 2010 inte-
grated development environment. The library used was
the MicrosoftW .NET Framework version 4. The deve-
lopment environment and base library have both been
selected based on personal preference and possibilities
that are enabled by the enhancements in these toolsconcerning ease of graphical user interface (GUI) deve-
lopment by separating the markup that describes the
GUI elements from programming logic that provides
the functionality.
The internet version of the application is hosted on a
semi-open platform, since a MicrosoftW Windows ope-
rating system is hosting an Apache™ HTTP Server web
server with installed PHP support and a free edition of
OracleW MySQL, providing a web interface to basically
the same, though slightly modified and recompiled, en-
gine as in the desktop version.
Results
The application that we developed has been named Ap-
plication for Visualization of Target Tissue in Electro-
poration, or ApiVizTEP in short. It is a Microsoft .NET
application bundled into an installation package together
with the .NET Framework version 4 Client Profile redis-
tributable installation, which enables the user to install
the application locally, provided the machine hardware
and operating system support this prerequisite frame-
work, as do most modern Windows operating systems
installed on compatible hardware.
At the start the application presents itself with a navi-
gational panel on the left-hand side of the window and a
help panel to the right (see Figure 2).
The help panel contains instructions on locating the
configuration of the system, i.e. directs to the config and
settings panels. These contain various model and system
settings that we describe here briefly: It is possible to in-
clude from two up to twelve needle electrodes in the
model that may be distributed into one, two, or more
(up to six) groups. One cathode and one or more anodes
or vice versa (one anode and one or more cathodes)
form such a group. These are defined in electroporation
studies in situations where applied voltages are different
for different pairs (or groups in general) of electrodes, as
currently electroporation devices mostly power only one
pair of electrodes at the same time [45]. The applied
voltages are configurable per group (see Figure 3). The
reversible electroporation threshold Erev as well as irre-
versible electroporation threshold Eirrev may also be set
(default settings 300 V/cm and 800 V/cm, respectively),
as these thresholds are highly dependent on the modeled
tissue (e.g. bone vs. muscle vs. liver etc.) as well as on
treatment parameters, e.g. number and duration of pulses
[46]. These thresholds may be set in three different units:
Figure 2 The help panel of ApiVizTEP with introduction and brief instructions.
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for changing the ratio of tumor size to healthy tissue
area, and for modifying the conductivity ratio of tumor
to healthy tissue, but these options are not, at present,
taken into account in calculations of the field strength,
although the effects of inhomogeneous conductivities can
be significant (see Discussion, Evaluation of accuracy and
usefulness of obtained solution).Figure 3 The configuration panel of ApiVizTEP with various options.An electroporation model studied in ApiVizTEP is fle-
xible in terms of adjustable tissue area (1.61 mm2 to
16129.00 mm2) and electrode diameter (0.10 mm to 2.00
mm, see Figure 4). The user interface for configuring has
also been designed with extensive error-checking capabi-
lities to prevent users from misconfiguring the model.
Once satisfied with the configuration, the user may
switch to the display panel, which contains the results
Figure 4 The settings panel of ApiVizTEP with various options.
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is divided into five areas; (1) the tissue area with color-
coded display of calculated electric field strength, elec-
trode positions and miniature color bar (legend); (2) the
large color bar and controls area (accessible via the color
controls button, see Figure 6); (3) the position fine-tun-
ing, coordinates and units panel; (4) the selected elec-
trode position and mouse cursor position bar; and (5)Figure 5 The display panel of ApiVizTEP with its 5 sub-sections.the position and display settings reset bar. The tissue
area, measuring 400 × 400 picture elements (pixels), is
displaying the results of our model. There are also the
X and Y axes and a circle representing the boundary be-
tween the tumor and the surrounding tissue. Currently,
this boundary serves no particular function other than
representing a target for our modeled ECT or NTIRE
efforts, a point on which we will elaborate later. What we
Figure 6 The display panel of ApiVizTEP with the color controls sub-section of the display panel visible. The color bar is annotated with
important field strength values (thresholds) and a gray color scheme has been selected to illustrate the results display adaptability (see for
comparison the same results displayed in “hot” color scheme in Figure 5).
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of which the values are encoded into color based on the
chosen palette (color bar), shown in Figure 6.
As described in the Background, coverage of the entire
target area with fields above reversible threshold is very im-
portant for successful ECT, and above irreversible thresh-
old for ablation of tissue by NTIRE. Thus, the learning
experience for the user is in the experimentation with the
chosen setup, by one or more of the following methods of
interaction: (1) repositioning of electrodes via mouse (drag
and drop) or eight buttons by a defined increment (up,
down, left, right, rotation around center point, towards or
away from the center point); (2) adjusting the number of
electrodes or the applied voltages (configuration panel); or
(3) varying tissue and electrode dimensions (settings panel).
The tools panel of the application contains two useful
analysis tools, one already developed (data collector) and
the other currently under development (data analyzer).
Data collector (as shown in Figure 7) is capable of main-
taining a record of our selected configurations that we
wish to analyze. An individual record holds information
about the electrode and voltage settings as well as analysis
performed at the instance of record creation; the maxi-
mum and minimum field strength, as well as percentage
of tumor and surrounding tissue subjected to irreversible
or reversible electric field strengths (see Figure 7).
ApiVizTEP also allows the user to save data via the
save & exit panel. An option is available to either save
configuration to a file that can be loaded at any time viaa key combination, or automatically at the next startup
of the application. Additionally, there is an option to re-
tain the data collected in the data collector.
For platform cross-compatibility and accessibility, a
web interface has been developed (Figure 8) that uses
the same engine as the standalone application; in other
words, the application has been recompiled without the
graphical interface and the interface built as a web appli-
cation. This is now part of an online e-learning course
presented at the EBTT International Workshop [40].
Discussion
The main result of the work presented in this paper is
the educational application that calculates and provides
visualization of the electric field in multiple needle elec-
trode electroporation, such as is commonly used in elec-
trochemotherapy [28] or tissue ablation by non-thermal
irreversible electroporation [39]. It has been developed
both as an installable desktop application and a web ser-
vice with a graphical interface.
ApiVizTEP from the user’s point of view
From the perspective of a potential user, the application
has been designed in an attempt to be both easy to use
and work with, and aesthetically pleasing. It is important
for a modern educational piece of software to be not only
functional in the educational sense, but also designed in a
way that is inviting the user to “play” with the various fea-
tures and modes of use, thus provoking a motivated self-
Figure 7 The tools panel of ApiVizTEP with data collector showing analysis of results obtained with configuration and settings shown
in Figures 3 and 4, respectively.
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our application has successfully incorporated these princi-
ples in the following sense; the amount of textual infor-
mation related to the understanding of user interface
functionality is minimal, the help section of the application
is mainly concerned with bridging the gap in knowledge of
the electroporation background and need not be focused
on the interface as it is minimalistic in design; since we
also aimed at flexibility in customizing and individualizing
the interface by the users themselves, we offer several dif-
ferent color options and palettes for visualizing the data as
well as six selectable color schemes of the graphical inter-
face (see Figure 3 – graphical user interface settings); and
finally, intelligent programming logic of error reporting
and warnings prevents the user from misconfiguring or
misusing the system and therefore failing to produce or
obtain erroneous results. Thus far feedback from users, i.e.
students at a workshop on electroporation, has been posi-
tive. While no formal study on the usability and user-
friendliness has been performed, based on individual oral
accounts of the learning experience, we can conclude that
the application is easy to use and the graphical interface is
intuitive; there have been no requests for clarification from
users during courses that incorporated ApiVizTEP, while
all participants successfully completed their assignments
that were based on work with the application.
Evaluation of accuracy and usefulness of obtained solution
With respect to the accuracy and reliability of the results
in light of present knowledge on mechanisms of ECT andNTIRE, there are a couple of points to consider. First, it
needs to be emphasized that due to optimization of speed
with which we obtain our results within ApiVizTEP and
our desire to enhance user experience – consequently
using an analytical model – we are limited by the need for
a low-complexity model of electroporation. The reason
for this is that an analytical model may be described and
solved without utilization of numerical methods which
come with high computational costs. Of main concern in
this regard are differences in electrical properties of tumor
and surrounding tissue. Since tumors normally exhibit
higher conductivity compared to the surrounding area
[48], local electric field strength inside the tumor can be
only a fraction of the field strength of the surrounding tis-
sue [20]. This inhomogeneity in tissue conductivity is at
the time of writing of this article incorporated into the
graphical user interface of ApiVizTEP, i.e. the user may set
tumor conductivity to surrounding tissue conductivity ra-
tio, but our mathematical model and therefore the field-
calculating engine do not take this ratio into account. We
therefore treat the entire area as homogeneous in con-
ductivity. The functionality of varying the tumor tissue
to surrounding tissue conductivity ratio is built into the
graphical user interface in anticipation of future work on
developing the analytical model still further. If possible, the
conductivity inhomogeneity will be accounted for in a
future model, i.e. a future version of the application. If it
is, however, impossible to obtain such a solution analy-
tically, the application will be extended with a numerical
engine.
Figure 8 The web version of ApiVizTEP as part of an e-learning application on electroporation.
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two-dimensional, as we have imagined our area of interest
to be a slice of three-dimensional space. This simplification
is made under the assumption that the generated field
is homogeneous along the electrode insertion axis if we ob-
serve a plane that is distant from electrode end points.
Since currently in ECT [28,29] and NTIRE [49-52] of deep-
seated tumors the electrodes are normally inserted
into tissue parallel to each other, the fact that we do
not consider the third spatial dimension is not of par-
ticular concern.Conclusions
The research and development presented in this paper is
grounded in decades of studying the phenomenon of
electroporation and the development of electroporation-
based technologies and treatments. It has resulted in a
software product aimed at educating a relatively small
but rapidly growing population of researchers and med-
ical staff in fields where applications utilizing electropor-
ation are growing in numbers, such as cancer treatment,
food processing and the environment (e.g. waste water
treatment, biofuel, etc.). As these applications mature
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educational solutions of this kind will become a neces-
sity, especially in the field of health care provision, since
ECT and NTIRE are highly successful modalities for
treatment of malignant tumors and tissue ablation, re-
spectively. The application presented here is portable
and accessible, as it can be distributed either as a stand-
alone software package that can be downloaded and in-
stalled, or as an online web application that is easily
accessed from any computer possessing browsing cap-
abilities. Feedback from students that have had an edu-
cational course of which ApiVizTEP is a part of, have
provided feedback that confirms the usefulness and ease
of use of the educational solution presented.
Availability and requirements
Project name: ApiVizTEP
Project home page: e.g. http://sourceforge.net/projects/
apiviztep/
Operating system(s): Web version: Platform indepen-
dent, Desktop version: Microsoft Windows XP and above
Programming language: Web version: PHP (GUI) and
C# (service), Desktop version: C#
Other requirements: Web version: Apache Server,
MySQL, XHTML, CSS, CodeIgniter library, IIS 7 Web
Server, .NET Framework v4, Desktop version: .NET
Framework v4
License: GNU General Public License v3
Any restrictions to use by non-academics: Desktop ver-
sion is subject to GNU GPL v3 license. Web-based version
is closed to all public access, due to it being part of a wider
educational framework that is not in public domain.
Appendix
This appendix provides a detailed mathematical deriva-
tion for electric field strength of two long thin parallel
cylindrical conductors. The basic theory of electric fieldFigure 9 Two long parallel cylindrical electrical conductors.supporting this derivation may be found in [40] or derived
by means of almost any comprehensive treatment of elec-
trostatic field theory that is found in literature, e.g. [53].
The general situation is illustrated by Figure 9 below.
We are looking for an analytical expression for the elec-
tric field of two long parallel cylindrical conductors of
diameter ρ0 distance dAB apart that carry electrical
charges +q and –q. Charges +q and –q are the actual
charges on the surface of the conductors, while charges
(+q) and (−q) are their mathematical equivalents, which
is why they are given in parentheses. These charges are
located eccentrically to the geometrical axes of the con-
ductors. The axes of the equivalent charges are also
known as the electrical axes and the distance between
these electrical axes and the geometrical axes is known
as eccentricity, denoted e. Via means of the geometrical
parameters of equipotential curves we determine the dis-
tance between the electrical axes, denoted by s, which
we find is related to the existing system parameters as









From Figure 9 it also follows:
e ¼ dAB
2










The electric potential in the area outside the conduc-
tors is defined by the equivalent charges:






and the voltage between the two conductors is the dif-
ference in potentials:
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If the voltage VAB(T) is known, the expression for the
unknown potential V(T) is given by:











The electric field strength E(T) is the absolute value
(length) of the vector E(T), obtained by means of the
gradient function of the scalar potential V(T):
E Tð Þ ¼ gradV Tð Þj j ¼ ∇V Tð Þj j: ðA:2Þ
The gradient in two-dimensional space described using
Cartesian coordinates x and y is:






The gradient operation applies to the expression log
(ρB/ρA) contained in A.1, where ρA and ρB are expressed
as (see Figure 9):
ρA ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ












xB0  xð Þ2 þ yB  yð Þ2
q ;
ðA:4Þ
for the particular case where the y coordinates of the
conductors’ geometrical axes are identical (and happen
to be equal to 0, see Figure 9). If this is not the case –
i.e. the coordinates of the geometrical centers are com-
pletely arbitrary – we need to determine the coordinates
of the electrical axes via a rotational transformation (i.e.
trigonometrically). For this general case, combining
equations A.1 – A.4 and accounting for the rotational
transformation to generalize eq. A.4, we get the follow-
ing set of expressions that represent the final and ge-




 2 þ y0A  y 2 
x0B  x
x0B  xð Þ2 þ y0B ð








x0A ¼ xA þ ej j⋅ cosΘ1; Θ1 ¼ arctan
yB  yA
xB  xA
x0B ¼ xB þ ej j⋅ cosΘ2; Θ2 ¼ arctan
yA  yB
xA  xB
y0A ¼ yA þ ej j⋅ sinΘ1;
y0B ¼ yB þ ej j⋅ sinΘ2
e ¼ dAB=2
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
dAB=2ð Þ2  ρ02
q
In eq. A.5 – A.7, VAB is the voltage on an electrode
pair (anode–cathode), dAB is the distance between the
electrodes, ρ0 is the electrode diameter, while x’A, y’A and
x’B, y’B are coordinates of the center of the electrode
mathematical equivalents (the electrical center x’A, y’A
and x’B, y’B of the electrodes is eccentric to the actual
geometrical center xA, yA and xB, yB due to finite i.e.
non-zero electrode diameter).
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